Capivasertib HR HER2-India Tabs 400mg 64s

Capivasertib is an AKT inhibitor used for HR /HER2breast cancer patients with alterations in PIK3CA, AKT1, or PTEN genes. The main job of Capivasertib is to stop this AKT signaling pathway thing, which is a big deal in breast cancer. You can get it as tablets, in 200 mg and 400 mg doses.

The advice is to take 400 mg of it twice a day for four days in a row, then take a break for three days. Each bottle has 64 tablets made for this routine.Here are the main features of Capivasertib:The main ingredient is Capivasertib.You’ve got 200 mg and 400 mg tablets.You take 400 mg twice a day, but then you take a break for three days.Each bottle has 64 pills.It comes in bottles.